Immunotherapy of equine sarcoid: Dose-escalation trial for the use of chimeric papillomavirus-like particles

Journal of General Virology

Volumn 89, Issue 1, 2008, Pages 138-147

  Mattil Fritz, Stephanie ^a   Scharner, Doreen ^b   Piuko, Konrad ^a   Thönes, Nadja ^a   Gissmann, Lutz ^a   Müller, Hermann ^b   Müller, Martin ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; PROTEIN E7; PROTEIN L1; TUMOR VACCINE; UNCLASSIFIED DRUG; VIROTHERAPY AGENT; VIRUS DNA;

ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG DOSE ESCALATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HORSE DISEASE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOTHERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PRIORITY JOURNAL; SARCOIDOSIS; TUMOR GROWTH; TUMOR REGRESSION; VACCINATION; VIRUS LIKE AGENT;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BIOPSY; BOVINE PAPILLOMAVIRUS 1; CHIMERA; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSARCOMA; HORSE DISEASES; HORSES; IMMUNOTHERAPY; MALE; PAPILLOMAVIRUS INFECTIONS; RECURRENCE; SARCOIDOSIS;

ANIMALIA; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PARVOVIRUS; EQUIDAE; PAPILLOMAVIRIDAE;

EID: 38349019686     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83266-0     Document Type: Article

References (39)

1. Amtmann, E., Müller, H. & Sauer, G. (1980). Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA. J Virol 35, 962-964.
2. Breitburd, F., Salmon, J. & Orth, G. (1997). The rabbit viral skin papillomas and carcinomas: a model for the immunogenetics of HPV-associated carcinogenesis. Clin Dermatol 15, 237-247.
3. Buck, C. B., Pastrana, D. V., Lowy, D. R. & Schiller, J. T. (2005). Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol Med 119, 445-462.
4. Campo, M. S. (1994). Vaccination against papillomavirus in cattle. Curr Top Microbiol Immunol 186, 255-266.
5. Campo, M. S. (1997). Bovine papillomavirus and cancer. Vet J 154, 175-188.
6. Campo, M. S. (2002). Animal models of papillomavirus pathogenesis. Virus Res 89, 249-261.
7. Carr, E. A., Theon, A. P., Madewell, B. R., Hitchcock, M. E., Schlegel, R. & Schiller, J. T. (2001). Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses. Am J Vet Res 62, 1212-1217.
8. Chambers, G., Ellsmore, V. A., O'Brien, P. M., Reid, S. W., Love, S., Campo, M. S. & Nasir, L. (2003). Association of bovine papillomavirus with the equine sarcoid. J Gen Virol 84, 1055-1062.
9. de Villiers, E. M., Fauquet, C., Broker, T. R., Bernard, H. U. & zur Hausen, H. (2004). Classification of papillomaviruses. Virology 324, 17-27.
10. Garcea, R. L. & Gissmann, L. (2004). Virus-like particles as vaccines and vessels for the delivery of small molecules. Curr Opin Biotechnol 15, 513-517.
11. Gissmann, L., Osen, W., Müller, M. & Jochmus, I. (2001). Therapeutic vaccines for human papillomaviruses. Intervirology 44, 167-175.
12. Goodrich, L., Gerber, H., Marti, E. & Antczak, D. F. (1998). Equine sarcoids. Vet Clin North Am Equine Pract 14, 607-623 (vii).
13. Greenstone, H. L., Nieland, J. D., de Visser, K. E., De Bruijn, M. L., Kirnbauer, R., Roden, R. B., Lowy, D. R., Kast, W. M. & Schiller, J. T. (1998). Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc Natl Acad Sci U S A 95, 1800-1805.
14. Kaufmann, A. M., Nieland, J., Schinz, M., Nonn, M., Gabelsberger, J., Meissner, H., Müller, R. T., Jochmus, I., Gissmann, L. & other authors (2001). HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination. Int J Cancer 92, 285-293.
15. Kaufmann, A. M., Nieland, J. D., Jochmus, I., Baur, S., Friese, K., Gabelsberger, J., Gieseking, F., Gissmann, L., Glasschroder, B. & other authors (2007). Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3). Int J Cancer 121, 2794-2800.
16. Kirnbauer, R. (1996). Papillomavirus-like particles for serology and vaccine development. Intervirology 39, 54-61.
17. Knottenbelt, D. C. (2005). A suggested clinical classification for the equine sarcoid. Clin Tech Equine Pract 4, 278-295.
18. Lancaster, W. D., Olson, C. & Meinke, W. (1977). Bovine papilloma virus: presence of virus-specific DNA sequences in naturally occurring equine tumors. Proc Natl Acad Sci U S A 74, 524-528.
19. Lazary, S., Gerber, H., Glatt, P. A. & Straub, R. (1985). Equine leucocyte antigens in sarcoid-affected horses. Equine Vet J 17, 283-286.
20. Lowy, D. R. & Frazer, I. H. (2003). Chapter 16: Prophylactic human papillomavirus vaccines. J Natl Cancer Inst Monogr 31, 111-116.
21. Lowy, D. & Howley, P. (2002). Papillomaviruses. In Fields Virology, 4th edn, pp. 2231-2264. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams and Willkins.
22. Müller, H. (1991). Papillomatosis of cattle and its relationship to equine sarcoid. Tierarztl Prax 19, 39-43.
23. Müller, M., Viscidi, R. P., Sun, Y., Guerrero, E., Hill, P. M., Shah, F., Bosch, F. X., Munoz, N., Gissmann, L. & other authors (1992). Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology 187, 508-514.
24. Müller, M., Zhou, J., Reed, T. D., Rittmüller, C., Burger, A., Gabelsberger, J., Braspenning, J. & Gissmann, L. (1997). Chimeric papillomavirus-like particles. Virology 234, 93-111.
25. Nasir, L. & Reid, S. W. (1999). Bovine papillomaviral gene expression in equine sarcoid tumours. Virus Res 61, 171-175.
26. Nicholls, P. K. & Stanley, M. A. (2000). The immunology of animal papillomaviruses. Vet Immunol Immunopathol 73, 101-127.
27. Nieland, J. D., Da Silva, D. M., Velders, M. P., de Visser, K. E., Schiller, J. T., Müller, M. & Kast, W. M. (1999). Chimeric papillomavirus virus-like particles induce a murine self-antigen-specific protective and therapeutic antitumor immune response. J Cell Biochem 73, 145-152.
28. Nixon, C., Chambers, G., Ellsmore, V., Campo, M. S., Burr, P., Argyle, D. J., Reid, S. W. & Nasir, L. (2005). Expression of cell cycle associated proteins cyclin A, CDK-2, p27kip1 and p53 in equine sarcoids. Cancer Lett 221, 237-245.
29. Ohlschlager, P., Osen, W., Dell, K., Faath, S., Garcea, R. L., Jochmus, I., Müller, M., Pawlita, M., Schäfer, K. & other authors (2003). Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. J Virol 77, 4635-4645.
30. Pastrana, D. V., Buck, C. B., Pang, Y. Y., Thompson, C. D., Castle, P. E., FitzGerald, P. C., Kruger Kjaer, S., Lowy, D. R. & Schiller, J. T. (2004). Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321, 205-216.
31. Ragland, K. W. L., Keown, G. F. H. & Spencer, G. R. (1970). Equine sarcoids. Equine Vet J 2, 2-11.
32. Rudolf, M. P., Fausch, S. C., Da Silva, D. M. & Kast, W. M. (2001). Human dendritic cells are activated by chimeric human papilloma-virus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro. J Immunol 166, 5917-5924.
33. Schäfer, K., Müller, M., Faath, S., Henn, A., Osen, W., Zentgraf, H., Benner, A., Gissmann, L. & Jochmus, I. (1999). Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection. Int J Cancer 81, 881-888.
34. Schiller, J. T. & Lowy, D. R. (2001). Papillomavirus-like particle vaccines. J Natl Cancer Inst Monogr, 50-54.
35. Schreckenberger, C. & Kaufmann, A. M. (2004). Vaccination strategies for the treatment and prevention of cervical cancer. Curr Opin Oncol 16, 485-491.
36. Sehr, P., Zumbach, K. & Pawlita, M. (2001). A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 253, 153-162.
37. Thönes, N. & Müller, M. (2007). Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes. Virology 369, 375-388.
38. Yuan, Z., Philbey, A. W., Gault, E. A., Campo, M. S. & Nasir, L. (2007). Detection of bovine papillomavirus type I genomes and viral gene expression in equine inflammatory skin conditions. Virus Res 124, 245-249.
39. Zur Hausen, H. (2006). Perspectives of contemporary papillomavirus research. Vaccine 24 (Suppl. 3), iii-iv.